Skip to content
Screener

Elevance Health ELV Corporate & Other — Restructuring Charges

Similar metrics at other companies

Azenta logo
AZTACorporate Segment — Restructuring Charges
$200K—
Huron Consulting Group logo
HURNCorporate Segment — Restructuring Charges
$1.5M-21.1%
Cooper-Standard Automotive logo
CPSCorporate Segment and Other Operating Segment — Restructuring Charges
$1.07M+2,713%
Olin logo
OLNCorporate/ other — Restructuring Charges
$9.1M+127%
TEC
TECHCorporate — Restructuring Charges
$688K+136%
Bruker logo
BRKRCorporate — Restructuring Charges
$1M-16.7%

Other financials

Income statement

See full
Revenue$50.5B+1.4%
Gross profit$45.0B+1.1%
Net income$1.5B-16.1%
EPS (diluted)$6.71-13.1%

Balance sheet

See full
Cash & equivalents$10.2B+19.5%
Total debt$30.7B+7.5%
Total equity$44.9B+2.7%
Total assets$126.44B+3.7%

Cash flow

See full
Operating cash flow$1.9B-6.9%
CapEx$287.0M+7.5%
Free cash flow$1.6B-9.0%

Valuation

See full
Market cap$84.88B+36.4%
Enterprise value$105.32B+28.1%
P/E17.1×+5.5×
P/S0.4×+0.1×

Profitability

See full
Gross margin89.1%+0.4pp
Net margin2.5%-0.4pp
FCF margin3.2%+0.4pp

Returns & leverage

See full
Return on equity11.2%-1.3pp
Debt / equity0.7×0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The source filing: Elevance Health’s 10-Q, filed July 15, 2026.

Filed
Jul 15, 2026, 11:27 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001156039-26-000060

The ending liability balance related to the employee termination costs under the Transformation Program at June 30, 2026 was $114, which included charges of $129 and payments of $15 made during the six months ended June 30, 2026.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Elevance Health's corporate & other — restructuring charges?
Elevance Health (ELV) reported corporate & other — restructuring charges of $1M in Q2 2026.
What does corporate & other — restructuring charges mean?
This metric tracks the non-recurring expenses recognized in the corporate segment due to organizational restructuring, such as severance, facility closures, or asset impairments. It reflects the accounting impact of significant changes to the company's operational structure. Investors analyze this to isolate core operating performance from one-time strategic adjustments.

Ask your AI about Elevance Health's corporate & other — restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude